ConductScience.org, home

Paper1751544

The trk family of tyrosine protein kinase receptors.

Barbacid M and 3 others. Biochim Biophys Acta, 1991. Cited by 164 papers, by iCite.

Cite this record

ConductScience Library. The trk family of tyrosine protein kinase receptors. Papers, record 1751544. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/1751544

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
The trk family of tyrosine protein kinase receptors.
PubMed
Journal
Biochim Biophys Acta
PubMed
Year
1991
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
164
iCite
Relative citation ratio, by iCite
3.3
iCite
Revised in PubMed
2019-06-09
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Barbacid MM
2Lamballe FF
3Pulido DD
4Klein RR

Source PubMed

Download CSV of authors

Topics12

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Multigene FamilyMajor topic
OncogenesMajor topic
Protein-Tyrosine KinasesMajor topic
Proto-Oncogene ProteinsMajor topic
Proto-OncogenesMajor topic
Amino Acid Sequence
Animals
Drosophila
Humans
Molecular Sequence Data
Neoplasms
Receptor, trkA

Source PubMed

Download CSV of topics

Cited by36

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 164 citations.

PMIDTitleJournalYearIn PapersSource
37958963Analysis of CD74 Occurrence in Oncogenic Fusion Proteins.Int J Mol Sci2023https://conductscience.org/library/papers/37958963PubMed
37869783Safety of current treatment options for NTRK fusion-positive cancers.Expert Opin Drug Saf2023https://conductscience.org/library/papers/37869783PubMed
37812694Phase separation underlies signaling activation of oncogenic NTRK fusions.Proc Natl Acad Sci U S A2023https://conductscience.org/library/papers/37812694PubMed
36362354Unleashing Intrinsic Growth Pathways in Regenerating Peripheral Neurons.Int J Mol Sci2022https://conductscience.org/library/papers/36362354PubMed
35907096Toward in vivo proof of binding of 18F-labeled inhibitor [18F]TRACK to peripheral tropomyosin receptor kinases.EJNMMI Res2022https://conductscience.org/library/papers/35907096PubMed
34531526NTRK insights: best practices for pathologists.Mod Pathol2022https://conductscience.org/library/papers/34531526PubMed
34176200Locally Recurrent Secretory Carcinoma of the Breast with NTRK3 Gene Fusion.Oncologist2021https://conductscience.org/library/papers/34176200PubMed
32394943The role of the TrkB-T1 receptor in the neurotrophin-4/5 antagonism of brain-derived neurotrophic factor on corticostriatal synaptic transmission.Neural Regen Res2020https://conductscience.org/library/papers/32394943PubMed
32093103Brain Metastases in Lung Cancers with Emerging Targetable Fusion Drivers.Int J Mol Sci2020https://conductscience.org/library/papers/32093103PubMed
31965543The Evolving Diagnostic and Treatment Landscape of NTRK-Fusion-Driven Pediatric Cancers.Paediatr Drugs2020https://conductscience.org/library/papers/31965543PubMed
31738427Tropomyosin receptor kinase (TRK) biology and the role of NTRK gene fusions in cancer.Ann Oncol2019https://conductscience.org/library/papers/31738427PubMed
31602824Differential Clinical Significance of Neurotrophin-3 Expression according to MYCN Amplification and TrkC Expression in Neuroblastoma.J Korean Med Sci2019https://conductscience.org/library/papers/31602824PubMed
30608586Neurotrophins and glial cell line-derived neurotrophic factor in the ovary: physiological and pathophysiological implications.Hum Reprod Update2019https://conductscience.org/library/papers/30608586PubMed
30333516NTRK fusion-positive cancers and TRK inhibitor therapy.Nat Rev Clin Oncol2018https://conductscience.org/library/papers/30333516PubMed
26125608AAV1.NT-3 gene therapy attenuates spontaneous autoimmune peripheral polyneuropathy.Gene Ther2016https://conductscience.org/library/papers/26125608PubMed
24860421Regulation of neurotrophin receptor (Trk) signaling: suppressor of cytokine signaling 2 (SOCS2) is a new player.Front Mol Neurosci2014https://conductscience.org/library/papers/24860421PubMed
24023598Tropomyosin-receptor-kinases signaling in the nervous system.Maedica (Bucur)2013https://conductscience.org/library/papers/24023598PubMed
23749991Nerve growth factor receptor TrkA, a new receptor in insulin signaling pathway in PC12 cells.J Biol Chem2013https://conductscience.org/library/papers/23749991PubMed
22474604NGF, brain and behavioral plasticity.Neural Plast2012https://conductscience.org/library/papers/22474604PubMed
20300619Neurotrophins regulate bone marrow stromal cell IL-6 expression through the MAPK pathway.PLoS One2010https://conductscience.org/library/papers/20300619PubMed

See all 36 cited byDownload CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
NTRK14914PubTator's text mininghttps://conductscience.org/library/genes/4914

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/1751544

GET https://conductscience.org/api/papers/v1/1751544/cited_by?page=2